Angiopoietin-2: A potential novel diagnostic marker in multiple myeloma
- 1 June 2011
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 44 (8-9) , 590-595
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Study of antioxidant levels in patients with multiple myelomaLeukemia & Lymphoma, 2009
- Serum concentrations of angiogenic cytokines in Waldenstrom macroglobulinaemia: the ratio of angiopoietin‐1 to angiopoietin‐2 and angiogenin correlate with disease severityBritish Journal of Haematology, 2007
- Angiogenesis in multiple myelomaEuropean Journal of Cancer, 2006
- Angiogenesis and Lung Cancer: Prognostic and Therapeutic ImplicationsJournal of Clinical Oncology, 2005
- Oxidant/antioxidant parameters and their relationship with medical treatment in multiple myelomaCell Biochemistry and Function, 2004
- The biology of VEGF and its receptorsNature Medicine, 2003
- New Approaches to the Treatment of Hepatic Malignancies Angiogenesis and Antiangiogenic Therapy of Colon Cancer Liver MetastasisAnnals of Surgical Oncology, 2003
- MIP-1α and TGF-β Production in CD34+ Progenitor–Stromal Cell Coculture Systems: Effects of Progenitor Isolation Method and Cell–Cell ContactBlood Cells, Molecules, and Diseases, 2000
- Bone marrow angiogenesis and progression in multiple myelomaBritish Journal of Haematology, 1994
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971